Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Bambusa Therapeutics Completes Patient Enrollment in the Phase 1b/2a Trial Evaluating BBT001 as a Treatment for Atopic Dermatitis

- Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic dermatitis (AD) and other type 2 inflammatory skin diseases - - Bambusa plans to announce topl...

2026-04-30 20:00 5619

Malaysia Healthcare Strengthens Presence in Myanmar as Demand for Trusted Treatment Abroad Grows

KUALA LUMPUR, Malaysia, April 30, 2026 /PRNewswire/ -- For many patients in Myanmar, seeking medical care abroad is becoming an increasingly considered decision, particularly for specialised treatments, second opinions, and long-term health management. As healthcare awareness grows, more patients...

2026-04-30 16:43 5586

Malaysia Healthcare Strengthens Presence in Myanmar as Demand for Trusted Treatment Abroad Grows

Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160

BEIJING, April 30, 2026 /PRNewswire/ -- Huahui Health today announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology immunotherapy. Under the agreement, BeOne Medicines is granted an ...

2026-04-30 16:28 5642

For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health

MAKATI CITY, Philippines, April 30, 2026 /PRNewswire/ -- Pfizer Philippines, together with healthcare professionals, has launched "For the Reasons that Matter", a public awareness campaign focused on adult respiratory health. Rolling out across the Philippines, Malaysia, Indonesia and Singapore, ...

2026-04-30 16:14 5548

Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

SINGAPORE and TAIPEI, April 30, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. ("Formosa", 6838.TW) and the Singapore Eye Research Institute ("SERI") are pleased to announce a strategic research collaboration to develop next-generation ophthalmic formulations. This partnership will leverage ...

2026-04-30 14:30 6470

New Classification System of Malocclusions Published in the Journal of Aligner Orthodontics (JAO) by Prof. Gang Shen's Team

SHANGHAI, April 30, 2026 /PRNewswire/ -- A seminal research paper titled "A New Classification System for Malocclusions with Facial Convexity"has been officially published in the 2026 Volume 1 issue of the Journal of Aligner Orthodontics (JAO). This article, authored by Professor Gang Shen and hi...

2026-04-30 13:33 5265

New Classification System of Malocclusions Published in the Journal of Aligner Orthodontics (JAO) by Prof. Gang Shen's Team

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

HONG KONG and HANGZHOU, China, April 30, 2026 /PRNewswire/ -- Hangzhou Diagens Biotech Co., Ltd. (HKEX: 2526, "Diagens"), a pioneer in medical imaging foundation models, today announced its first annual results since its listing. The report marks a pivotal milestone in the company's transition fr...

2026-04-30 13:18 6571

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

Haier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025

AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent productivity platform QINGDAO, China, April 30, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medi...

2026-04-30 12:35 5038

2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

SHANGHAI, April 30, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, today announced that two latest clinical study results of its novel Nectin‑4 targeting ADC (R&D code: 9MW2821) in cervical cancer will be ...

2026-04-30 12:26 5838

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

Elisrasib monotherapy demonstrates notable efficacy in three major tumor types at its recommended phase 2 dose (RP2D, 600 mg QD). Phase 2 clinical outcomes include: * 2L+ KRAS G12Ci–naïve NSCLC: ORR of 58.8%, mPFS of 12.2 months * 2L+ colorectal cancer (CRC): ORR of 46.9%, mPFS of 9.5 months ...

2026-04-30 11:20 5988

CMEF 2026 wraps up in Shanghai: a global stage for medical breakthroughs and future trends

SHANGHAI, April 30, 2026 /PRNewswire/ -- The 93rd China International Medical Equipment Fair (CMEF), together with its concurrent industry events, has successfully concluded on April 12 at the National Exhibition and Convention Center (Shanghai) after four days of exhibitions and exchanges. Under...

2026-04-30 10:26 4748

CMEF 2026 wraps up in Shanghai: a global stage for medical breakthroughs and future trends

ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing in advanced immunology technologies. The partne...

2026-04-30 08:30 5855

Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions

HONG KONG, April 30, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the American Diabetes Association's (ADA's) 2026 Scientific Sessions, taking place June 5–8, 2026 in New Orleans, Louisiana. The presentat...

2026-04-30 08:10 5694

ACROBiosystems collaborates with Carterra, accelerating large-scale characterization of potential drug candidates

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, announces its collaboration with Carterra, a company focused on innovative technologies designed to accelerate the discovery...

2026-04-30 08:00 4793

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

* TLX597-Tx is a PSMA[1]-targeting small molecule radioligand therapy (RLT) candidate, designed to improve quality-of-life and efficacy in earlier-stage prostate cancer. * OPTIMAL-PSMA[2] initial dosimetry data demonstrate low salivary gland and kidney uptake, supporting dose intensification....

2026-04-30 05:00 6338

New study demonstrates up to 73% reduction in genome analysis errors using AI-trained models versus standard approaches

SAN JOSE, Calif., April 29, 2026 /PRNewswire/ -- Complete Genomics , a U.S.-based leader in genomic sequencing technologies, todayannounced results demonstrating that AI-trained variant calling mode...

2026-04-29 23:02 5597

Navinci launches Omni kit - the next generation of spatial interactomics

UPPSALA, Sweden, April 29, 2026 /PRNewswire/ -- Navinci today announces the launch ofOmni, breakthrough fully customized kits designed to transform how scientists study protein function directly in tissue. Omni provides cutting-edge spatial interactomics capabilities, enabling researchers to map ...

2026-04-29 22:32 4207

WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access

* Contributing to the United Nations Sustainable Development Goals, driving equitable access to healthcare through technology and innovation * Enhancing governance transparency and effectiveness to create long-term value for all stakeholders * Empowering employees and fostering shared value ...

2026-04-29 20:30 5099

Vivacta Bio Closed Series A and Series A+ Financing of Over US$50 Million

Backed by Decheng Capital, Loyal Valley Capital, OrbiMed, and Other Renowned Investors SHANGHAI, April 29, 2026 /PRNewswire/ -- Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta" or "Vivacta Bio"), an innovative biotechnology company focused on revolutionizing in vivo CAR-T therapies, announc...

2026-04-29 20:15 3412

United Imaging Healthcare Releases 2025 Annual Report and Q1 2026 Results, Delivering Strong Growth with Accelerated Global Expansion

SHANGHAI, April 29, 2026 /PRNewswire/ -- United Imaging Healthcare (688271.SH)，a global innovator in advanced medical imaging technologies and intelligent healthcare solutions, announced its 2025 annual results and Q1 2026 performance, both delivering solid growth. In 2025, the company reported ...

2026-04-29 20:00 5296

1 ... 30 31 323334 35 36 ... 647

Week's Top Stories

Most Reposted

Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub

[Picked up by 309 media titles]

2026-07-30 10:45